0 CHECKOUT

PRODUCT FILTERS

REGION

1,335
666
663
578
578

COUNTRY

563
141
84
82
81

CATEGORIES

  • 353
  • 266
  • 258
  • 255
  • 216
  • 209
  • 181
  • 163
  • 160
  • 148
  • 145
  • 137
  • 100
  • 98
  • 42

PRICE

600
1,179
2,023
3,876

PUBLISHED

198
1,209
2,003
3,876

PRODUCT TYPE

3,064
361
245
165
37
2
1
1

Oncology Drugs

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Global and Chinese Somatostatin Acetate Industry - 2016

The 'Global and Chinese Somatostatin Acetate Industry - 2016' is a professional and in-depth study on the current state of the global Somatostatin Acetate industry with a focus on the Chinese market....

Published:  April 2016
Price:  From

Global and Chinese 15-28-Somatostatin-28 (CAS 38916-34-6) Industry - 2016

The 'Global and Chinese 15-28-Somatostatin-28 Industry, - 2016' is a professional and in-depth study on the current state of the global 15-28-Somatostatin-28 industry with a focus on the Chinese market....

Published:  April 2016
Price:  From

Global and Chinese Cepharanthine (CAS 481-49-2) Industry - 2016

The 'Global and Chinese Cepharanthine Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Cepharanthine industry with a focus on the Chinese...

Published:  April 2016
Price:  From

Global and Chinese Hydroxyurea (CAS 127-07-1) Industry - 2016

The 'Global and Chinese Hydroxyurea Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Hydroxyurea industry with a focus on the Chinese market....

Published:  April 2016
Price:  From

Global and Chinese Dexamethasone dipropionate (CAS 55541-30-5) Industry - 2016

The 'Global and Chinese Dexamethasone dipropionate Industry - 2016' is a professional and in-depth study on the current state of the global Dexamethasone dipropionate industry with a focus on the Chinese...

Published:  April 2016
Price:  From

Global and Chinese Dexamethasone Palmitate Industry - 2016

The 'Global and Chinese Dexamethasone Palmitate Industry, - 2016' is a professional and in-depth study on the current state of the global Dexamethasone Palmitate industry with a focus on the Chinese...

Published:  April 2016
Price:  From

Global and Chinese Dexamethasone-17-acetate (CAS 1177-87-3) Industry - 2016

The 'Global and Chinese Dexamethasone-17-acetate Industry, - 2016' is a professional and in-depth study on the current state of the global Dexamethasone-17-acetate industry with a focus on the Chinese...

Published:  April 2016
Price:  From

Global and Chinese Triamcinolone (CAS 124-94-7) Industry - 2016

The 'Global and Chinese Triamcinolone Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Triamcinolone industry with a focus on the Chinese...

Published:  April 2016
Price:  From

Kidney Cancer Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

'Kidney Cancer Drugs Market (Major Drugs: Afinitor (Everolimus), Avastin (Bevacizumab), Inlyta (Axitinib), Nexavar (Sorafenib), Proleukin (Aldesleukin), Sutent (Sunitinib), Torisel (Temsirolimus), Votrient...

Published:  January 2015
Price:  From

CINV Existing and Pipeline Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

'CINV Existing and Pipeline Drugs Market (Aloxi, Zofran Generic, Kytril Generic, Emend, Akynzeo, SUSTOL and Rolapitant) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020' Chemotherapy...

Published:  December 2014
Price:  From

NDDS in Cancer Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

This study on novel drug delivery systems (NDDS) in cancer therapy comprises study of technologies such as embolization devices, liquid embolics and nanoparticles that offer unique approaches in cancer...

Published:  October 2014
Price:  From

Ablation Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

'Ablation Technologies Market (Applications: Cardiovascular, Gynecology, Pain Management, Oncology, Urology, Ophthalmology; Technologies: Radiofrequency, Light/Laser, Electrical, Ultrasound, Microwave,...

Published:  August 2014
Price:  From

Ablation Technologies Market by Product, Application - Global Forecasts to 2019

Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General & Cosmetic Surgery, Cardiovascular, Cancer, Ophthalmology,...

Published:  September 2014
Price:  From

Corporate Reputation of Pharma in 2014 - a Perspective of Cancer Patient Groups - 2nd Edition

- Findings based on a survey of 197 patient groups with an interest in cancer from 37 countries - Survey conducted November 2014 to January 2015 This independent study, funded by the author, represents...

Published:  March 2015
Price:  From

Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2014

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis....

Published:  July 2014
Price:  From

Companion Diagnostics in Personalized Medicine and Cancer Therapy

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic...

Published:  June 2014
Price:  From

Non-Tyrosine Kinase Inhibitors in Oncology, 2015 - 2025

Over decades, the oncology market has been led by surgery, chemotherapy and radiotherapy. The non-specificity of chemotherapy/radiotherapy and limitations of surgery has expanded the focus of many pharmaceutical...

Published:  April 2015
Price:  From

Global Non Small Cell Lung Cancer Market & Pipeline Insight

Lung cancer has become one of the most prevalent cause of cancer related morbidity and mortality in past several decades across the world. Lungs are a pair of spongy tissues present in the thoracic...

Published:  January 2015
Price:  From

Global Non-small Cell Lung Cancer Market 2014-2018

About Non-small Cell Lung Cancer Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading cause of cancer...

Published:  September 2014
Price:  From

Global Multiple Myeloma Drugs Market 2015-2019

About Multiple Myeloma Multiple myeloma is a common cancer that affects the plasma cells, a type of white blood cell. It begins in the plasma cells of bone marrow. The primary function of the plasma...

Published:  December 2014
Price:  From
Loading Indicator

Our Clients